United States Artificial Intelligence in Diabetes Management Market Is Anticipated to Grow at a CAGR of 35.7% by 2027
Growing prevalence of gestational diabetes mellitus (GDM) among the pregnant women in United States ranges from 3% to 7%. Women with GDM do not continue to have hyperglycemia after delivery. However, 50% of them who have a GDM history have the risk to develop type 2 diabetes followed by their GDM diagnosis. Research & development in the artificial intelligence in diabetes management market has shown that this threat can be managed and reduced by using the right technological solutions.
View full press release